Data on TERN-101 Show Promise for NASH Treatment

In this installment of “Just a Phase,” we look at the phase 2a LIFT trial of TERN-101 (Terns ...

OCTOBER 28, 2021

FAST Score Can Stratify NASH Risk in Diabetics

A recently developed scoring system could be a useful tool to noninvasively identify people with type 2 diabetes ...

MAY 25, 2021

Registry Finds NAFLD, NASH Not So Silent After All

Patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis can suffer a variety of related ...

MAY 13, 2021

Endoscopic Resurfacing Looks Promising For Diabetics With NASH

A single duodenal mucosal resurfacing procedure safely elicits favorable disease-modifying metabolic effects in ...

JANUARY 7, 2021

Noninvasive Tests for NASH: Progress But Not Perfection

The first study of its kind has pinpointed optimal thresholds for two noninvasive tests to identify significant ...

JANUARY 7, 2021

Experimental NASH Treatment Produces Suggestions of Benefit in Trial

Twelve weeks of therapy with the farnesoid X receptor (FXR) agonist tropifexor (Novartis) produces dose-dependent ...

MAY 29, 2020

Trial Results Mixed for Frontrunning NASH Therapy

For treatment of non-alcoholic steatohepatitis, obeticholic acid (OCA) met one of its primary end points but not ...

MARCH 13, 2020

NASH/NAFLD Highlights From the 2019 Liver Meeting

In this installment of ‘Expert Picks,’ Rohit Loomba, MD, from the University of California, San Diego, ...

FEBRUARY 28, 2020

AI Tool Finds NASH Patients

Boston—The development of a new machine learning tool may help health care providers identify patients at ...

FEBRUARY 21, 2020

Artificial Intelligence Shows Promise For Identifying Undiagnosed NASH

An artificial intelligence algorithm may prove useful for detecting missed cases of non-alcoholic steatohepatitis, ...

FEBRUARY 15, 2019

Bariatric Surgery Keeps NASH at Bay for Years

San Francisco—The benefits of bariatric surgery for the liver appear to be robust and durable, according to a ...

FEBRUARY 13, 2019

Management of NAFLD: Use of a New Therapeutic Approach to Reduce Risk Factors

This article discusses recent advances in the assessment and treatment of NAFLD, and describes Hepaxa, the first ...

FEBRUARY 11, 2019